Repligen
RGEN
163.81
-6.48
-3.81%
Repligen
US · RGEN
#1445 by market cap
Listed 1970
163.81
-6.48
-3.81%
Periodic snapshot; not a real-time feed.
· 2026-11-20 19:30
Recent news
-
Rating change
CCORF Maintains Repligen(RGEN.US) With Hold Rating, Maintains Target Price $180Market Newswire · 2026/10/28
-
Company notice
CelcomDigi: Change in Boardroom - MR JØRGEN CHRISTIAN ARENTZ ROSTRUPBursa Malaysia · 2022/11/30
-
Rating change
A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $180 to $235Market Newswire · 2026/10/29
-
Rating change
RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $200Market Newswire · 2026/10/28
-
Rating change
Wells Fargo Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $185Market Newswire · 2026/7/30
-
Barclays Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $225Market Newswire · 2026/10/7
-
Company notice
Nike | 8-K: Jørgen Vig Knudstorp Nominated to Join NIKE Board of DirectorsSEC · 2025/6/26
-
Rating change
CCORF Maintains Repligen(RGEN.US) With Hold Rating, Raises Target Price to $180Market Newswire · 2026/10/19
-
Rating change
Wells Fargo Initiates Repligen(RGEN.US) With Buy Rating, Announces Target Price $185Market Newswire · 2026/8/17
-
Rating change
J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $175Market Newswire · 2026/7/29
-
Rating change
Repligen (RGEN) Receives a Buy From J.P. MorganTipRanks · 2026/10/17
-
Barclays Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $225Market Newswire · 2026/10/28
-
Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207Market Newswire · 2026/11/11
-
Company notice
CDB: Change in Boardroom - MR JØRGEN CHRISTIAN ARENTZ ROSTRUPBursa Malaysia · 2023/9/29
-
RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $200Market Newswire · 2026/11/2
-
Rating change
Stifel Maintains Repligen(RGEN.US) With Buy RatingMarket Newswire · 2026/9/16
-
Rating change
UBS Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $225Market Newswire · 2026/9/29
-
J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $205Market Newswire · 2026/10/30
-
Rating change
J.P. Morgan Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $200Market Newswire · 2026/10/17
-
Rating change
CCORF Maintains Repligen(RGEN.US) With Hold Rating, Maintains Target Price $145Market Newswire · 2026/7/29
-
Rating change
Stifel Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $207Market Newswire · 2026/7/30
-
Rating change
A Quick Look at Today's Ratings for Repligen(RGEN.US), With a Forecast Between $175 to $200Market Newswire · 2026/7/29
-
Rating change
Evercore Maintains Repligen(RGEN.US) With Buy Rating, Raises Target Price to $160Market Newswire · 2026/7/6
-
Rating change
RBC Capital Maintains Repligen(RGEN.US) With Buy Rating, Maintains Target Price $160Market Newswire · 2026/7/24
-
Rating change
William Blair Maintains Repligen(RGEN.US) With Buy RatingMarket Newswire · 2026/7/22
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Repligen discussion 0 comments